跳至主要内容
临床试验/NCT07644806
NCT07644806尚未招募不适用

Olive Oil Supplementation to Enhance Exercise Tolerance in Cardiac Rehabilitation in Patients With Heart Failure With Reduced Ejection Fraction: The OLEA-HF Study

Old Dominion University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40
试验地点
1

研究概览

简要总结

The OLEA-HF study aims to explore whether daily supplementation of extra-virgin olive oil (EVOO) for 12 weeks during participation in a cardiac rehabilitation program (standard of care) is feasible in patients with heart failure with reduced ejection fraction (HFrEF). The investigators will also determine the effects of EVOO on functional capacity and quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with HFrEF with left ventricular ejection fraction ≤35 %.
  • Referred to and enrolled in the standard cardiac rehabilitation program at Sentara Cardiac Rehabilitation Center, but has not yet initiated/started cardiac rehabilitation (i.e., has not attended the first cardiac rehab session).
  • Able and willing to comply with study procedures and provide informed consent.

排除标准

  • Co-morbidity expected to limit survival (e.g., terminal illness).
  • End-stage renal disease.
  • Unstable fluid overload.
  • Current pregnancy (self-disclose).
  • Habitual use of EVOO greater than 4 tablespoons per day.
  • Known allergy or sensitivity to olive oil or its components.
  • Unwillingness or inability to incorporate EVOO or dietary recommendations.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Salvatore Carbone

Associate Professor and Nutrition Program Director

Old Dominion University

研究点 (1)

Loading locations...

相似试验

Olive Oil Supplementation for Heart Failure With... | 临床试验